EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring

Lucía Quintana-Castanedo iD, Rocío Maseda iD, Silvia Sánchez-Ramón iD, Nora Butta iD, Marta Molero-Luis iD, María G Crespo iD, Antonio Buño iD, Sara Herráiz-Gil iD, Carlos León iD, Alberto Varas iD, Lidia M Fernández-Sevilla iD, Pilar Zuluaga iD und 5 weitere

Nutrients · 2026

DOI: 10.3390/nu18020232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Lucía Quintana-Castanedo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital La Paz, 28046 Madrid, Spain. Hauptthemen laut MEDLINE: Zinc, Nutritional Status, Epidermolysis Bullosa Dystrophica. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HULP-IdiPaz Dermatology Service and FIBHULP, MCIN/AEI/10.13039/501100011033, MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Recessive dystrophic epidermolysis bullosa (RDEB) is a severe congenital genodermatosis characterized by skin and mucosa fragility, chronic inflammation, recurrent infections and high nutritional demands due to increased metabolism and epithelial barrier-related losses, placing patients at risk of zinc deficiency. We aimed to investigate the clinical relevance and biochemical determinants of zinc deficiency as a potentially modifiable contributor to disease burden in RDEB.

Methods

In this cross-sectional study (n = 84), serum zinc levels were analyzed in association with sex, age, disease severity, percentage of body surface area (BSA) affected, inflammatory markers, infection burden, and common clinical complications including anemia and growth impairment.

Results

Zinc deficiency, defined as levels below 670 µg/L, was identified in 35% of patients and became more frequent after age 5 and during adulthood, particularly among those with more severe disease. Deficiency was strongly associated with anemia, inflammation, infection burden, growth impairment, and extensive skin involvement. A revised cutoff of 780 µg/L is proposed, showing improved diagnostic performance for identifying patients at risk of systemic complications, and offering a more suitable threshold for starting preventive supplementation. Multivariate logistic modeling confirmed that low serum zinc independently predicted anemia risk, alongside transferrin saturation and C- reactive protein levels. Serum albumin was identified as the strongest determinant of zinc levels, partially mediating the effects of inflammation and skin involvement.

Conclusions

These findings identify serum zinc as a clinically relevant marker of nutritional status and complication burden in RDEB. While no causal or therapeutic effects can be inferred from this cross-sectional study, the strong and biologically plausible associations observed suggest a rationale for systematic monitoring and correction of zinc deficiency as part of comprehensive supportive care, and warrant prospective studies to assess clinical benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZincNutritional StatusEpidermolysis Bullosa DystrophicaHumansFemaleBiomarkersCross-Sectional StudiesMaleChildAdolescentAdultChild, PreschoolYoung AdultInfantDeficiency DiseasesInflammation

Stichwörter der Autor:innen

albuminanemiainflammationrecessive dystrophic epidermolysis bullosaserum zinc levelsskin fragilityzinc deficiency

Substanzen

ZincBiomarkers

Autor:innen und Institutionen

  • Department of Dermatology, Hospital La Paz, 28046 Madrid, Spain.
  • Department of Dermatology, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
  • Department of Immunology, Hospital Clínico San Carlos, 28040 Madrid, Spain.
  • Immunology Group, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
  • Department of Hematology and Hemotherapy, Hospital La Paz, 28046 Madrid, Spain.
  • Coagulopathies and Alterations in Haemostasis Group, IdiPAZ Health Research Institute, Hospital La Paz, 28046 Madrid, Spain.

ORCID-Profile: Lucía Quintana-Castanedo, Rocío Maseda, Silvia Sánchez-Ramón, Nora Butta, Marta Molero-Luis, María G Crespo, Antonio Buño, Sara Herráiz-Gil, Carlos León, Alberto Varas, Lidia M Fernández-Sevilla, Pilar Zuluaga, Raúl de Lucas, Marcela Del Río, Ángeles Vicente, María J Escámez, Rosa Sacedón

Förderung

  • HULP-IdiPaz Dermatology Service and FIBHULP
  • MCIN/AEI/10.13039/501100011033
  • MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe"
  • Instituto de Salud Carlos III, co-financed by the European Union through NextGenerationEU
  • DEBRA Austria, co-funded by DEBRA Sweden and EB-LOPPET
  • EB Research Network (León-1)

Zitieren

APA

Quintana-Castanedo, L., Maseda, R., Sánchez-Ramón, S., Butta, N., Molero-Luis, M., Crespo, M. G., Buño, A., Herráiz-Gil, S., León, C., Varas, A., Fernández-Sevilla, L. M., Zuluaga, P., de Lucas, R., Del Río, M., Vicente, Á., Escámez, M. J., & Sacedón, R. (2026). Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring. Nutrients. https://doi.org/10.3390/nu18020232

Vancouver

Quintana-Castanedo L, Maseda R, Sánchez-Ramón S, Butta N, Molero-Luis M, Crespo MG, et al. Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring. Nutrients. 2026. doi:10.3390/nu18020232

BibTeX
@article{QuintanaCastanedo2026,
  author = {Quintana-Castanedo, Lucía and Maseda, Rocío and Sánchez-Ramón, Silvia and Butta, Nora and Molero-Luis, Marta and Crespo, María G and Buño, Antonio and Herráiz-Gil, Sara and León, Carlos and Varas, Alberto and Fernández-Sevilla, Lidia M and Zuluaga, Pilar and de Lucas, Raúl and Del Río, Marcela and Vicente, Ángeles and Escámez, María J and Sacedón, Rosa},
  title = {Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18020232}
}
Kostenlos starten →